Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

The project has four roving clinics that influencers are contracted to visit to brand HIV prevention as hip and ‘cool’ ...